Clinical Trials Logo
  1. Home
  2. Cutaneous Lupus Erythematosus
  3. NCT01300208

To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus

Cutaneous Lupus Erythematosus Clinical Trial

Official title:
A Phase 2, Pilot, Multicenter, Sequential, Ascending Dose Study to Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus

Clinical Trial Summary

This is the first study in cutaneous lupus erythematosus subjects to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of CC-11050.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01300208
Study type Interventional
Source Amgen
Contact
Status Completed
Phase Phase 2
Start date October 1, 2010
Completion date March 1, 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT01776190 - Low-dose UVA1 Radiation in Cutaneous Lupus Patients N/A
Completed NCT00420173 - Interdisciplinary Study Group of Lupus Erythematosus (ISGLE) N/A
Terminated NCT04809623 - Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) Phase 1
Terminated NCT01470313 - A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus Phase 1
Completed NCT01146444 - Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE) N/A
Completed NCT03134222 - Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE) Phase 2
Completed NCT01629784 - Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus N/A
Completed NCT00470912 - Sunscreen RV 2457C in Photoinduced CLE Phase 3
Completed NCT01841619 - IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus Phase 0
Completed NCT00523588 - Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser Phase 2
Recruiting NCT06411106 - Deep Phenotyping of Cutaneous Lupus Erythematosus N/A
Not yet recruiting NCT06015737 - A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus Phase 3
Terminated NCT01498406 - Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus Phase 2
Completed NCT04647708 - Study of M5049 in CLE and SLE Participants Phase 1
Completed NCT03817424 - A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis Phase 1
Active, not recruiting NCT03260166 - Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus Phase 2
Completed NCT00317681 - Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE) Phase 2
Completed NCT04781816 - Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus Phase 2